Obesity-depression: clinical evaluation with a new anorexigenic agent.
D000328:Adult; D001067:Appetite Depressants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001835:Body Weight; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003913:Dextroamphetamine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009765:Obesity / Q000188:drug therapy*; D010633:Phenmetrazine / Q000627:therapeutic use; D010919:Placebos
D001067:Appetite Depressants; D007093:Imidazoles; D007211:Indoles; D010919:Placebos; D003913:Dextroamphetamine; D010633:Phenmetrazine